|
|
||||||||
J Thorac Cardiovasc Surg 2006;132:628-632
© 2006 The American Association for Thoracic Surgery
Evolving Technology |
Division of Cardiac Surgery, McGill University, Montreal, Quebec, Canada.
Presented in part at the Annual Congress of The American Heart Association, Dallas, Tex, Nov 14, 2005.
Received for publication December 8, 2005; revisions received April 11, 2006; accepted for publication May 24, 2006. * Address for reprints: Dominique Shum-Tim, MD, Division of Cardiac Surgery, The Montreal General Hospital, MUHC, 1650 Cedar Ave, Suite C9-169, Montreal, Quebec, Canada H3G 1A4 (Email: dshumtim{at}yahoo.ca).
OBJECTIVE: Direct intramyocardial injection is a common route of donor cell administration for myocardial cell therapy. Studies have demonstrated a significant and rapid loss of implanted cells, which is thought to be biologically caused. We hypothesized that mechanical loss of cells from the contracting myocardium might actually be the main culprit.
METHODS: Intramyocardial injections of fluorescent microspheres (10 µm) were carried out in both small and large animal models. The hearts of Lewis rats (250-350 g) received 3 x 106 microspheres injected into the left ventricular myocardium. Rats were divided evenly between two experienced operators. The nonbeating (n = 2) and beating (n = 5) hearts of piglets (7.5-7.8 kg) received 3 x 106 microspheres. The hearts were excised within 10 minutes, and the microspheres retained in the myocardium were quantified with fluorescent flow cytometry.
RESULTS: In the beating-heart rat model, the microsphere retention rates after a single injection were similar with and without purse-string occlusion of needle puncture sites and slightly lower than after multiple site injections (6.19% ± 4.05% vs 5.44% ± 5.66% vs 8.83% ± 3.29%). There were no significant operator-dependent differences. The retention rates in beating porcine hearts were higher than those in the rats (P < .05) but markedly lower than those in nonbeating porcine hearts (11.1% vs 67.4%).
CONCLUSION: Mechanical leakage and washout may account for a major portion of cell loss after cell implantation, and efforts aimed at reducing mechanical loss in the beating heart may yield a greater benefit than those targeting biologic loss alone.
This article has been cited by other articles:
![]() |
A. M. Abarbanell, A. C. Coffey, J. W. Fehrenbacher, D. J. Beckman, J. L. Herrmann, B. Weil, and D. R. Meldrum Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann. Thorac. Surg., September 1, 2009; 88(3): 1036 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Boudoulas and A. K. Hatzopoulos Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease Dis. Model. Mech., July 1, 2009; 2(7-8): 344 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L Kao, W. Browder, and C. Li Cellular Cardiomyoplasty: What Have We Learned? Asian Cardiovasc Thorac Ann, January 1, 2009; 17(1): 89 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guo, H. Kh. Haider, C. Wang, R.-S. Tan, W. S.N. Shim, P. Wong, and E. K.W. Sim Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation Ann. Thorac. Surg., December 1, 2008; 86(6): 1841 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche, O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, L. Trinquart, J.-T. Vilquin, J.-P. Marolleau, B. Seymour, J. Larghero, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation Circulation, March 4, 2008; 117(9): 1189 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chachques, J. C. Trainini, N. Lago, M. Cortes-Morichetti, O. Schussler, and A. Carpentier Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study Ann. Thorac. Surg., March 1, 2008; 85(3): 901 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Atoui, J.-F. Asenjo, M. Duong, G. Chen, R. C.-J. Chiu, and D. Shum-Tim Marrow Stromal Cells as Universal Donor Cells for Myocardial Regenerative Therapy: Their Unique Immune Tolerance Ann. Thorac. Surg., February 1, 2008; 85(2): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Wang, C.-H. Chen, W.-W. Lin, S.-M. Hwang, P. C.H. Hsieh, P.-H. Lai, Y.-C. Yeh, Y. Chang, and H.-W. Sung Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction Cardiovasc Res, February 1, 2008; 77(3): 515 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, P. Song, Y. Tang, X.-l. Zhang, S.-h. Zhao, Y.-j. Wei, and S.-s. Hu Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1234 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guo, H. Kh. Haider, W. S.N. Shim, R.-S. Tan, L. Ye, S. Jiang, P. K. Law, P. Wong, and E. K.W. Sim Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1332 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nussbaum, E. Minami, M. A. Laflamme, J. A. I. Virag, C. B. Ware, A. Masino, V. Muskheli, L. Pabon, H. Reinecke, and C. E. Murry Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response FASEB J, May 1, 2007; 21(7): 1345 - 1357. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |